Comparison of HPV neutralizing and IgG antibodies in unvaccinated female adolescents

Author:

Yao Xingmei1,Chu Kai2,Zhao Jun1,Hu Yuemei2,Lin Zhijie3,Lin Bizhen3,Chen Qi1,Li Yafei1,Zhang Qiufen3,Fang Mujin1,Huang Shoujie1,Wang Yingbin1,Su Yingying1,Wu Ting1,Zhang Jun1,Xia Ningshao14

Affiliation:

1. State Key Laboratory of Molecular Vaccinology & Molecular Diagnostics, National Institute of Diagnostics & Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, China

2. Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, Jiangsu, China

3. Xiamen Innovax Biotech Co., Ltd., Xiamen, 361022, Fujian, China

4. Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen, 361102, Fujian, China

Abstract

Aims: To analyze the consistency between HPV-neutralizing antibodies and specific total IgG antibodies in unvaccinated females. Materials & methods: Serum samples from 978 unvaccinated Chinese females aged 9–26 years were measured for antibodies against HPV-16 and HPV-18 using simultaneous pseudovirus-based neutralization assay and ELISA. Results: There was a moderate level of consistency between HPV-neutralizing antibodies and specific IgG in females aged 18–26 years (Cohen's κ coefficient for HPV-16 and HPV-18: 0.52 and 0.38) and poor consistency in those aged 9–17 years (Cohen's κ coefficient <0.05). However, Cohen's κ coefficient remained almost unchanged in sensitivity analysis when the IgG antibody cutoff value was raised. Conclusion: HPV-neutralizing antibodies are a more specific indicator for the evaluation of HPV natural humoral immunity.

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences

Fujian Provincial Health Education Joint Research Project

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3